Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy

By Mikhailidis D. P.   Sibbring G. C.   Ballantyne C. M.   Davies G. M.   Catapano A. L.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 2009-2026

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes

By Raz Itamar   Chen Yu   Wu Mei   Hussain Shehla   Kaufman Keith D.   Amatruda John M.   Langdon Ronald B.   Stein Peter P.   Alba Maria  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 537-550

Informa Healthcare

Access to resources Recommend Favorite

The Effects of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Platelet and Inflammatory Biomarkers in Patients with Metabolic Syndrome

By  

Cardiology, Vol. 125, Iss. 2, 2013-05 ,pp. : 74-77

Karger

Access to resources Recommend Favorite

Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients

By Catapano Alberico L.   Davidson Michael H.   Ballantyne Christie M.   Brady William E.   Gazzara Russell A.   Tomassini Joanne E.   Tershakovec Andrew M.  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2041-2053

Informa Healthcare

Access to resources Recommend Favorite

Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe–statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia

By Assmann Gerd   Kannenberg Frank   Ramey Dena R.   Musliner Thomas A.   Gutkin Stephen W.   Veltri Enrico P.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 249-259

Informa Healthcare

Access to resources Recommend Favorite